EC
KROS icon

EcoR1 Capital’s Keros Therapeutics KROS Stock Holding History

EcoR1 Capital’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-187,500
Closed -$1.91M – 43
2025
Q1 		$1.91M Hold
187,500
– – 0.11% 35
2024
Q4 		$2.97M Hold
187,500
– – 0.12% 47
2024
Q3 		$10.9M Hold
187,500
– – 0.37% 41
2024
Q2 		$8.57M Hold
187,500
– – 0.26% 42
2024
Q1 		$12.4M Buy
+187,500
New +$11.1M 0.32% 41
2020
Q3 		– Sell
-220,216
Closed -$8.26M – 59
2020
Q2 		$8.26M Buy
+220,216
New +$6.78M 0.62% 29

Other funds holding KROS

ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return